OVB vs. ROQ, TCF, SNG, EVG, MTFB, DEST, BSFA, RENE, OBD, and PYC
Should you be buying Ovoca Bio stock or one of its competitors? The main competitors of Ovoca Bio include Roquefort Therapeutics (ROQ), Theracryf (TCF), Synairgen (SNG), Evgen Pharma (EVG), Motif Bio (MTFB), Destiny Pharma (DEST), BSF Enterprise (BSFA), ReNeuron Group (RENE), Oxford BioDynamics (OBD), and Physiomics (PYC). These companies are all part of the "biotechnology" industry.
Ovoca Bio vs.
Ovoca Bio (LON:OVB) and Roquefort Therapeutics (LON:ROQ) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.
Roquefort Therapeutics has higher revenue and earnings than Ovoca Bio. Roquefort Therapeutics is trading at a lower price-to-earnings ratio than Ovoca Bio, indicating that it is currently the more affordable of the two stocks.
In the previous week, Ovoca Bio's average media sentiment score of 0.00 equaled Roquefort Therapeutics'average media sentiment score.
Ovoca Bio has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, Roquefort Therapeutics has a beta of 0.05, suggesting that its share price is 95% less volatile than the S&P 500.
1.7% of Roquefort Therapeutics shares are held by institutional investors. 44.7% of Ovoca Bio shares are held by insiders. Comparatively, 60.4% of Roquefort Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Ovoca Bio received 17 more outperform votes than Roquefort Therapeutics when rated by MarketBeat users.
Roquefort Therapeutics' return on equity of -27.05% beat Ovoca Bio's return on equity.
Summary
Roquefort Therapeutics beats Ovoca Bio on 6 of the 10 factors compared between the two stocks.
Get Ovoca Bio News Delivered to You Automatically
Sign up to receive the latest news and ratings for OVB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ovoca Bio Competitors List
Related Companies and Tools
This page (LON:OVB) was last updated on 1/22/2025 by MarketBeat.com Staff
Free OVB Stock Alerts